DRUG

carbon dot probes

3 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for carbon dot probes

Alzheimer 3

Mediator Outcome Score Tier Lit. status Trial
GFAP cognitive decline 0.208 Mid novel signal none
GFAP cognitive impairment 0.208 Mid novel signal none
GFAP Alzheimer disease 0.208 Mid novel signal none

Clinical trials

0 registered trials for carbon dot probes

Source: ClinicalTrials.gov

No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.

Search ClinicalTrials.gov →